Bristol-Myers Squibb Company (BMY) vs Stryker Corporation (SYK)
BMY leads on 12 of 17 compared metrics.
A side-by-side comparison of Bristol-Myers Squibb Company and Stryker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 16, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BMY
Bristol-Myers Squibb Company
$56.24Healthcare
SYK
Stryker Corporation
$310.58Healthcare
Total return — BMY vs SYK
growth of $100 · last 30yBMY +163.4%SYK +4798.7%SYK compounded faster
Log scale — wide-divergence pair
BMY SYK
BMY vs SYK: by the numbers
- •SYK is the larger company ($119.06B vs $114.38B market cap).
- •BMY trades at the lower earnings multiple (15.80 vs 35.95 P/E).
- •BMY converts more revenue to profit (15.01% vs 13.21% net margin).
- •SYK grew revenue faster over the past five years (11.42% vs 2.52% CAGR).
- •BMY pays the higher dividend yield (4.45% vs 1.11%).
Which is better, BMY or SYK?
Metric tally: BMY 12 · SYK 5It depends on what you're optimizing for:
ValueBMY(lower P/E)
GrowthSYK(faster 5Y revenue CAGR)
IncomeBMY(higher dividend yield)
QualityBMY(higher ROIC)
Metrics side by side
Valuation
| Metric | BMY | SYK |
|---|---|---|
| P/E ratio | 15.80● | 35.95 |
| Forward P/E | 9.17● | 18.56 |
| P/S ratio | 2.37● | 4.75 |
| P/B ratio | 5.73 | 5.22● |
| PEG ratio | 1.68● | 5.16 |
| EV / EBITDA | 10.90● | 21.49 |
| FCF yield | 10.36%● | 3.81% |
Profitability
| Metric | BMY | SYK |
|---|---|---|
| Gross margin | 68.75%● | 63.67% |
| Operating margin | 25.67%● | 21.34% |
| Net margin | 15.01%● | 13.21% |
| ROE | 36.25%● | 14.52% |
| ROIC | 13.90%● | 8.53% |
Dividends
| Metric | BMY | SYK |
|---|---|---|
| Dividend yield | 4.45%● | 1.11% |
| Payout ratio | 72.25% | 40.52% |
Growth (annualized)
| Metric | BMY | SYK |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 11.42%● |
| EPS CAGR (5Y) | 9.38% | 14.79%● |
| FCF CAGR (5Y) | -2.50% | 11.01%● |
| Total return CAGR (5Y) | 0.46% | 4.98%● |
Frequently asked
- Which is better, BMY or SYK?
- It depends on your goal. value: BMY (lower P/E); growth: SYK (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 12 to 5.
- Is BMY or SYK cheaper?
- On trailing earnings, BMY is cheaper: BMY trades at a 15.80 P/E and SYK at 35.95.
- Which has grown faster, BMY or SYK?
- Over the past five years, SYK grew revenue faster — BMY at a 2.52% CAGR versus SYK at 11.42%.
- Does BMY or SYK pay a bigger dividend?
- BMY yields 4.45% and SYK yields 1.11% based on trailing dividends and the latest price.
- Is BMY or SYK more profitable?
- BMY runs the higher net margin — BMY at 15.01% versus SYK at 13.21%.
- Which has been the better investment, BMY or SYK?
- Over the past 10-year, SYK delivered the higher annualized total return — BMY at 1.00% versus SYK at 11.71%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioStryker P/E ratioBristol-Myers Squibb dividend yieldStryker dividend yieldBristol-Myers Squibb ROEStryker ROEBristol-Myers Squibb operating marginStryker operating marginBristol-Myers Squibb revenue growthStryker revenue growthBristol-Myers Squibb free cash flowStryker free cash flow
Bristol-Myers Squibb & Stryker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 16, 2026.